INTERNATIONAL PATENT: MEDIMMUNE LIMITED FILES APPLICATION FOR "INHALER AND CAPSULE FOR DELIVERING THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES"

GENEVA, Dec. 1 -- MEDIMMUNE LIMITED (1 Francis Crick Avenue, Cambridge Biomedical CampusCambridge Cambridgeshire CB2 0AA) filed a patent application (PCT/EP2025/063702) for "INHALER AND CAPSULE FOR DELIVERING THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES" on May 19, 2025. With publication no. WO/2025/242605, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEATON, Dan (ASTRAZENECA PHARMACEUTICALS LP, 1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437)

Abstract: A preloaded inhaler (100) comprises a ...